LNA Sante SA (LNA) AI Stock Analysis

• Market Cap: €266.76M
• Dividend Yield: 2.51%
• Average Volume (3M): 3.10K
• Price to Earnings (P/E): 12.8
• Beta (1Y): 0.49
• Revenue Growth: 13.31%
• EPS Growth: -13.07%
• Country: FR
• Employees: 9,000
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Care Facilities
• EPS (TTM): 1.10
• Shares Outstanding: 10,709,416
• 10 Day Avg. Volume: 2,764
• 30 Day Avg. Volume: 3,095
• PEG Ratio: -1.69
• Price to Book (P/B): 0.82
• Price to Sales (P/S): 0.32
• P/FCF Ratio: 3.62
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: €33.00
• Price Target Upside: 32.00% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1

• Rating: 65 Neutral
• Price Target: €28.00 ▲(12.00% Upside)

LNA Sante SA's overall stock score is driven by strong financial performance and attractive valuation. However, technical analysis indicates bearish momentum, which poses a risk. The company's ability to maintain cash flow and manage leverage will be key to future performance.

LNA Sante SA Business Overview & Revenue Model

Company Description

LNA Santé SA engages in the management and operation of health establishments. The company operates retirement homes, medical and rehabilitation care, home hospital, mental health clinic, and health center. LNA Santé SA was founded in 1990 and is based in Vertou, France.

How the Company Makes Money

LNA generates revenue through multiple key streams, primarily from the provision of residential care services in its nursing homes and assisted living facilities. The company charges fees for accommodation, daily care, and specialized medical services, which are often covered by governmental health programs or private insurance. Additionally, LNA may engage in partnerships with local health authorities and institutions, which can provide funding and resources for its operations. The organization also benefits from economies of scale, allowing it to optimize operational efficiencies and reduce costs, further enhancing its profitability.

LNA Sante SA Financial Statement Overview

Summary

LNA Sante SA is performing well with consistent revenue growth and stable operational margins. Despite high leverage, the company effectively generates cash, supporting its financial flexibility. Continued focus on managing costs and leveraging cash flow for strategic investments will be crucial for sustaining growth.

Income Statement

LNA Sante SA has shown consistent revenue growth over the years, with a notable increase from 2023 to 2024. The gross profit margin has weakened compared to previous years, which could indicate rising costs or pricing pressures. However, the EBIT and EBITDA margins remain stable, suggesting operational efficiency. The net profit margin shows a slight decline, which could be a concern if it continues.

Balance Sheet

The company's debt-to-equity ratio is relatively high, reflecting significant leverage. However, the return on equity has been stable, indicating effective use of shareholder funds. The equity ratio is moderate, suggesting a balanced capital structure. Overall, the balance sheet exhibits some risk due to high debt levels, but equity growth is positive.

Cash Flow

LNA Sante SA has demonstrated strong operating cash flow relative to net income, highlighting efficient cash generation. The free cash flow growth has been positive, supporting future investments or debt reduction. The free cash flow to net income ratio is healthy, indicating good cash availability after capital expenditures.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	863.42M	806.60M	736.09M	728.22M	689.49M	573.89M
Gross Profit	151.96M	91.10M	241.09M	622.42M	577.87M	481.03M
EBITDA	140.10M	144.85M	144.63M	141.82M	131.64M	108.17M
Net Income	20.77M	21.82M	23.41M	25.81M	23.51M	7.81M
Balance Sheet
Total Assets	1.57B	1.54B	1.51B	1.51B	1.53B	1.50B
Cash, Cash Equivalents and Short-Term Investments	68.04M	75.06M	77.17M	101.98M	152.12M	121.39M
Total Debt	901.42M	876.44M	887.67M	911.55M	1.00B	971.50M
Total Liabilities	1.25B	1.21B	1.20B	1.21B	1.31B	1.30B
Stockholders Equity	318.92M	313.81M	299.24M	289.33M	216.09M	188.65M
Cash Flow
Free Cash Flow	52.22M	71.24M	84.56M	89.86M	65.98M	132.74M
Operating Cash Flow	64.82M	82.06M	97.50M	103.20M	79.92M	146.50M
Investing Cash Flow	-14.73M	-23.72M	-15.69M	-41.99M	-27.65M	-205.94M
Financing Cash Flow	-52.40M	-88.80M	-106.69M	-110.88M	-21.53M	40.24M

LNA Sante SA Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 25.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:LNA, the sentiment is Negative. The current price of 25 is below the 20-day moving average (MA) of 26.83, below the 50-day MA of 28.76, and below the 200-day MA of 25.08, indicating a bearish trend. The MACD of -0.99 indicates Positive momentum. The RSI at 30.78 is Neutral, neither overbought nor oversold. The STOCH value of 38.56 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for FR:LNA.

LNA Sante SA Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
EQS	67 Neutral	€606.08M	16.79	16.40%	3.09%	4.45%	-14.08%
LNA	65 Neutral	€266.76M	12.78	6.64%	2.51%	13.31%	-13.07%
CLARI	60 Neutral	€1.60B	―	-1.70%	―	1.98%	85.87%
GDS	54 Neutral	€1.09B	―	-4.36%	―	4.70%	-0.33%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
MAAT	48 Neutral	€71.52M	―	―	―	52.55%	-5.97%
EMEIS	40 Neutral	€2.23B	0.02	-16.69%	―	6.29%	-100.37%

LNA Sante SA Corporate Events

LNA Santé Achieves 2024 Targets Amidst Healthcare Challenges

LNA Santé reported strong financial results for 2024, meeting its targets despite challenges in the healthcare sector. The company achieved a 6.7% increase in operating sales and a 7.7% rise in net operating profit, while managing its debt effectively. The company plans to continue its growth trajectory in 2025, targeting a 6% increase in operating sales and focusing on strategic acquisitions and facility transformations to meet healthcare demands.